Evaluation of Beckman Coulter DxI 800 immunoassay system using clinically oriented performance goals

Clinical Biochemistry

Volumn 47, Issue 16-17, 2014, Pages 158-163

  Akbas, Neval ^a   Schryver, Patricia G ^a   Algeciras Schimnich, Alicia ^a   Baumann, Nikola A ^a   Block, Darci R ^a   Budd, Jeffrey R ^b   Gaston, S J Stephen ^b   Klee, George G ^a  

^a MAYO CLINIC   (United States)

^b Beckman Coulter Inc   (United States)

Author keywords

Analytical performance; Beckman Coulter DxI 800; Immunoassay; Precision; Quality control

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ALPHA FETOPROTEIN; ANTIBODY; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; CYANOCOBALAMIN; ERYTHROPOIETIN; ESTRIOL; FERRITIN; FOLIC ACID; FOLLITROPIN; HUMAN GROWTH HORMONE; HYDROCORTISONE; INHIBIN A; INTRINSIC FACTOR; LIOTHYRONINE; LUTEINIZING HORMONE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROLACTIN; THYROGLOBULIN; THYROPEROXIDASE ANTIBODY; THYROXINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FREE LIOTHYRONINE INDEX; HUMAN; IMMUNOASSAY; IMMUNOASSAY ANALYZER; LIMIT OF DETECTION; LINEAR SYSTEM; MAJOR CLINICAL STUDY; QUANTITATIVE ANALYSIS; PROCEDURES; REPRODUCIBILITY;

FERRITINS; IMMUNOASSAY; REPRODUCIBILITY OF RESULTS; THYROXINE; TRIIODOTHYRONINE;

EID: 84908658572     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.08.005     Document Type: Article

References (25)

1. Clinical laboratory improvement amendments law and regulations Available at:, [Accessed July 5, 2014]. http://wwwn.cdc.gov/clia/Regulatory/default.aspx.
2. User verification of performance for precision and trueness; approved guideline. EP15-A2 2006, vol. 25. Clinical and Laboratory Standards Institute. 2nd ed. N.R. Carey, F.P. Anderson, H. George, A.E. Hartman, V.K. Janzen, A. Kallner (Eds.).
3. Evaluation of precision performance of quantitative measurement methods; approved guideline. EP05-A2 2004, vol. 24. Clinical and Laboratory Standards Institute. D.W. Tholen, A. Kallner, J.W. Kennedy, J.S. Krouwer, K. Meier (Eds.).
4. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. EP06-A 2003, vol. 23. Clinical and Laboratory Standards Institute. D.W. Tholen, M. Kroll, J.R. Astles, A.L. Caffo, T.M. Happe, J. Krouwer (Eds.).
5. User evaluation of between-reagent lot variation; approved guideline. EP26-A 2013, vol. 33. Clinical and Laboratory Standards Institute. N.B. Person, J.R. Budd, K. De Vore, A.P. Durham, V.M. Genta, S. Huang (Eds.).
6. Thompson M., Ellison S.L., Wood R. Harmonized guidelines for single laboratory validation of methods of analysis (IUPAC Technical Report). Pure Appl Chem 2002, 74(5):835-855.
7. Tate J., Panteghini M. Standardisation - the theory and the practice. Clin Biochem Rev 2007, 28:127-130.
8. BIVDA Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Off J Eur Communities 1998, 41. [L331/1-L331/37].
9. BIVDA Revision of Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Public Consultation. European Commission, Health and Consumers Directorate-General June 2010.
10. BIVDA Revision of Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Summary of responses to the Public Consultation. European Commission, Health and Consumers Directorate-General February 2011.
11. Jhang J.S., Chang C.-C., Fink D.J., Kroll M.H. Evaluation of linearity in the clinical laboratory. Arch Pathol Lab Med 2004, 128(1):44-48.
12. CAP 2012 calibration verification/linearity program user's guide 2012, 35. College of American Pathologists, Northfield.
13. Dalenberg D.A., Schryver P.G., Klee G.G. Analytical performance specifications: relating laboratory performance to quality required for intended clinical use. Clin Lab Med 2013, 33(1):55-73.
14. Fraser C.G., Petersen P.H. Analytical performance characteristics should be judged against objective quality specifications. Clin Chem 1999, 45(3):321-323.
15. Ricos C., Alvarez V., Cava F., Garcia-Lario J.V., Hernández A., Jimènez C.V., et al. Current databases on biologic variation: pros, cons and progress. Scand J Clin Lab Invest 1999, 59(7):491-500.
16. Westgard J.O. Desirable specifications for total error, imprecision, and bias, derived from intra- and inter-individual biologic variation http://www.westgard.com/biodatabase1.htm.
17. Klee G.G. A conceptual model for establishing tolerance limits for analytic bias and imprecision based on variations in population test distributions. Clin Chim Acta 1997, 260(2):175-188.
18. Klee G.G., Schryver P., Kisabeth R. Analytic bias specifications based on the analysis of effects on performance of medical guidelines. Scand J Clin Lab Invest 1999, 59(7):509-512.
19. Klee G.G. Establishment of outcome-related analytic performance goals. Clin Chem 2010, 56(5):714-722.
20. The guide to the expression of uncertainty in measurement 1993, International Organization for Standardization, Geneva, Switzerland. 1st ed. BIPM (Ed.).
21. Letellier M., Levesque A., Daigle F., Grant A. Performance evaluation of automated immunoassays on the Technicon Immuno 1 system. Clin Chem 1996, 42(10):1695-1701.
22. Stieber P., Molina R., Gion M., Gressner A., Troalen F., Holdenrieder S., et al. Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access GI Monitor assay on the UniCel DxI 800 Immunoassay System. Clin Chem Lab Med 2008, 46(5):600-611.
23. Yagmur E., Driesch R., Gressner A.M., Kiefer P. Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay. Clin Chem Lab Med 2006, 44(4):420-422.
24. Holdenrieder S., Molina R., Gion M., Gressner A., Troalen F., Auge J.M., et al. Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access OV Monitor assay on the UniCel DxI 800 Immunoassay System. Clin Chem Lab Med 2008, 46(5):588-599.
25. Badiou S., Bariolet S., Laurens C., Aillaud N., Bargnoux A.S., Mariano-Goulart D., et al. Comparison of isotopic and immunoenzymatic methods for folate and vitamin B12 determination. Clin Lab 2010, 56(11-12):547-552.